From intensifying therapy in ctDNA-positive bladder cancer to scaling it back in ctDNA-negative colon cancer, new data from ...

“ur finding enables the safe discontinuation of follow-up after 6 years, leading to an improvement in quality of life and a reduction in health care system costs,” study researchers wrote.

A new blood test for cancer DNA — the genetic code that differentiates cancer from healthy tissue — allows doctors to ...

Median disease-free survival (DFS) increased from 4.8 months with placebo to 9.9 months with adjuvant atezolizumab (Tecentriq ...

What was supposed to be a 50th birthday celebration and vacation turned out to be something much different for Erin Grimm.

By combining LED technology and nanomaterials, researchers have created a therapy that eliminates cancer cells using ...

Patients with chemorefractory metastatic colorectal cancer derive no overall survival benefit from giving anti-EGFR ...

Colon cancer symptoms in women are similar to those in men, but they can be confused with gynecological issues, like cramping ...

Tumor boards are an invaluable tool to share knowledge and ensure optimal treatment for people with cancer.The conversations ...

Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from small lesions or polyps, its exact causes are unknown — only a few risk factors ...

Pancreatic cancer incidence is rising among younger adults, particularly those aged 15 to 39, due to lifestyle and genetic factors. Key risk factors include obesity, smoking, alcohol consumption, and ...